Strategy to improve the female fertility in the general gynecologist's office: use of a nutritional supplement based on myo-inositol/D-chiro-inositol and antioxidants

Gynecol Endocrinol. 2022 Apr;38(4):275-278. doi: 10.1080/09513590.2021.2015759. Epub 2021 Dec 21.

Abstract

Subfertility is more than a quality-of-life problem as it has a substantial negative public health impact. Polycystic ovary syndrome (PCOS) is one of the most common causes of subfertility, affecting one out of 10 women in reproductive age. Among PCOS women undergoing assisted reproductive technology, treatment based on myo-inositol and high doses of D-chiro-inositol has been shown to increase pregnancy rate and number of live births, reduce ovarian hyperstimulation syndrome and improve oocyte quality. A preparation based on myo-inositol and high doses of D-chiro-inositol, together with antioxidants, vitamins, and minerals, could have beneficial effects and be an optimal strategy to improve female fertility in the general gynecologist's office. The aim of this review is to highlight the role of inositol and its isomers in improving fertility of women with PCOS.

Keywords: D-chiro-inositol; Subfertility; antioxidants; myo-inositol; polycystic ovary syndrome.

Publication types

  • Review

MeSH terms

  • Antioxidants / therapeutic use
  • Female
  • Fertility
  • Humans
  • Inositol* / therapeutic use
  • Polycystic Ovary Syndrome* / complications
  • Polycystic Ovary Syndrome* / drug therapy
  • Pregnancy
  • Pregnancy Rate

Substances

  • Antioxidants
  • Inositol